Pharmacological doses of atrial natriuretic peptide were infused into rats to study its effect on intestinal transport. Saline control or two concentrations ofrat a atrial natriuretic peptide (0.06 or 1-0 nmollminlkg) were administered intravenously (1 ml) over one hour. Jejunal net transport of water and electrolytes was measured with a plasma-like luminal electrolyte solution using a 'closed loop' technique. Distal colonic potential difference and arterial blood pressure were monitored continuously. Blood samples for analysis of plasma atrial natriuretic peptide concentrations were taken at the end of the experiments. Plasma concentrations were increased (mean (SD) (2.1 (0.5) and 24.0 (1.1) nmol/l respectively) compared with the controls (0.023 (0.016) nmol/l). Blood pressure dropped by 30% (p<005) in both groups of rats receiving atrial natriuretic peptide but remained unchanged when control saline was infused. Jejunal net absorption was reduced (p<0.01) only in animals receiving the higher concentration ofpeptide (H20 from 173 (33) to 64 (69) ,ul.h-lhcm-, Na from 25.7 (5.3) to 10.9 (8.9) ,umol.h-1.cm-2). Distal colonic potential difference was not affected by atrial natriuretic peptide. In conclusion massive doses of atrial natriuretic peptide are required to produce any change in intestinal salt and water transport in normal, non-volume expanded rats; these effects could be a nonspecific or 'toxic' response.
The effect of extracellular fluid expansion on the kidney and intestine has been known for some time.'2 Richet and Hornych showed that extracellular fluid expansion diminished reabsorption of sodium in the proximal tubule and in the jejunum.2 They also excluded any role of angiotensin and aldosterone and they claimed general humoral or physical factors to be responsible for the observed phenomena. Further studies showed that this was a short acting mechanism which probably acted on sodium transport processes. The discovery of atrial natriuretic peptide in 19783 provided a putative mediator for this effect. Although atrial natriuretic peptide is very active in the renal tubule, data on its effects on intestinal water and electrolyte transport are still contradictory. Increased absorption,4 reduced absorption, and even secretion5`8 have been described in laboratory animals, and no effects could be found in humans.9 ' 10 Results have been confused by the wide range of doses used in these studies, as well as by experimental variables such as nonstandardisation of volume loading.
In our preceding study using pathophysiological doses of atrial natriuretic peptide in normal human volunteers no effect on small intestinal electrolyte transport and potential difference was found.'0 The present study was Japan). Blood pressure was measured at 10 minute intervals by sphygmomanometry."
Atrial natriuretic peptide (Sigma Chemical, St Louis, Missouri, USA) was dissolved in isotonic saline and stored at -80°C in 1-2 ml aliquots in polyethylene tubes. The doses were allocated blindly on the day of study after a randomised numbered code for three experimental groups: group 1 to receive isotonic saline (control, n= 12); group 2 a atrial natriuretic peptide (0-06 nmol/min/kg rat, n= 10); group 3 a atrial natriuretic peptide (1-0 nmol/min/kg, n= 10). At the end of the study two control rats were discarded because of leakage of the intravenous line and one rat from each peptide series died during peptide infusion. Finally, data from 10 control rats and nine animals from both the lower and the higher peptide group were analysed. Figure 1 shows the study design. The preparation procedure was usually completed within 45 minutes. After 30 (Fig 2) .
Colonic potential difference was not affected by atrial natriuretic peptide (Fig 2) . Similar initial readings (group 1: 237 (8.6), group 2: 25.3 (10.8), group 3: 25.4 (7.8) mV) were followed by an increase of the potential difference towards the end of the experiment in all animals.
Jejunal net transport data are shown in the Table. Water, sodium, and chloride net absorption was significantly reduced in group 3 (p<00 1), while transport in group 2 was not significantly different from that of the controls (group 1). Potassium absorption (groups 1 and 2) turned to net secretion in group 3 (Table) .
Discussion
Atrial natriuretic peptide in pathophysiological doses has no effect on intestinal ion transport in normal human volunteers.9 '0 Higher doses have been used in previous animal studies. 47 21 The present study in anaesthetised rats was designed to evaluate the intestinal response to increasing pharmacological doses of atrial natriuretic peptide. The larger dose produced a response. The resulting plasma concentrations were found to be in the higher range when compared with most other studies'5 21 and above the pathophysiological concentrations known to occur, for example, in congestive heart failure.22 Possible toxicity of atrial natriuretic peptide was suggested when two rats died during the infusion. Data on controls, on the other hand, were not different from previously reported data.2324
Systolic blood pressure was reduced slightly in our controls compared with that in conscious animals,'6 a known side effect of pentobarbitone anaesthesia.26 Similar low blood pressures were reached with both atrial natriuretic peptide doses after 30 minutes of infusion (Fig 2) . Although the larger dose produced a more rapid decline in blood pressure, none of these differences was significant and no further changes were observed during the jejunal transport study. In a well designed study Seymour et al'8 infused rats with increasing doses of atrial natriuretic peptide (0.020-0 1 nmol/min/kg). A maximum effect on the vascular system was found in the dose range 0.06-0 1 nmol/min/kg intravenously, and even tenfold higher concentrations, as used in our study, did not further influence blood pressure. The moderate increase in blood pressure during the jejunal transport study might be interpreted as a volume dependent effect because it was also observed in the controls (Fig 2) .
In vivo recording of colonic potential difference does not allow separation of electrogenic chloride secretion from electrogenic sodium absorption, as changes in electroneutral transport processes remain undetected. In contrast to the in vitro flux chamber data of Moriarty et al, 27 performed with high serosal atrial natriuretic peptide concentrations (10-5-O1-9 mol/l), we could detect no changes in distal colonic potential difference. This virtually excludes a possible atrial natriuretic peptide-induced chloride secretion, which should have resulted in an acute increase in potential difference. The progressive increase in potential difference in all animals after 90 minutes (Fig 2) is most likely a mineralocorticoid effect, possibly induced by the anaesthesia and surgical procedure at the beginning of the experiment. 28 Jejunal net absorption of water and electrolytes was reduced by >50% only in group 3 (Table) . The general hypotensive effect of atrial natriuretic peptide cannot explain this phenomenon as the smaller dose produced a similar hypotensive response but did not alter net jejunal transport (Fig 2) 
